AI-116 significantly reduces glutamate-induced toxicity in vitro, exceeding that of existing FDA
registered drug for dementia, Donepezil (originally marketed as Aricept)
Ann: Positive results from AI-116 in vitro studies, page-2
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $13.49M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $31.82K | 4.542M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 3680984 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 5730411 | 8 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |